ロード中...
Pharmacokinetics of Tedizolid in Subjects with Renal or Hepatic Impairment
Two open-label, single-dose, parallel-group studies were conducted to characterize the pharmacokinetics of the novel antibacterial tedizolid and the safety of tedizolid phosphate, its prodrug, in renally or hepatically impaired subjects. Tedizolid pharmacokinetics in subjects with severe renal impai...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4249404/ https://ncbi.nlm.nih.gov/pubmed/25136024 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03431-14 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|